aldosterone has been researched along with Adrenocortical Carcinoma in 49 studies
Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Imaging with [¹²³I]iodometomidate ([¹²³I]IMTO) has been shown to diagnose adrenocortical lesions with high sensitivity and specificity." | 7.79 | [¹²³I]Iodometomidate imaging in adrenocortical carcinoma. ( Allolio, B; Bock, S; Buck, AK; Fassnacht, M; Haenscheid, H; Hahner, S; Knoedler, P; Kreissl, MC; Reiners, C; Saeger, W; Schirbel, A; Verburg, FA, 2013) |
| " The purpose of the present study was to determine the effect of endothelin-1 (ET-1) and angiotensin II (Ang II), two potent vasoconstrictors that are also involved in heart failure, on aldosterone secretion by human adrenocortical carcinoma NCIH295R cells grown in 96-well plates." | 7.72 | Synergistic stimulation of aldosterone production in human adrenocortical carcinoma NCI-H295R cells by endothelin-1 and angiotensin II. ( Hu, CW; Jeng, AY; Webb, RL, 2004) |
| "Aldosterone-producing adrenocortical carcinoma (APAC) is a rare cause of hypertension often diagnosed late because of paucity of information." | 6.43 | Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. ( Fassina, A; Nussdorfer, GG; Pessina, AC; Rossi, GP; Seccia, TM, 2005) |
| "His aldosterone/renin ratio was high and plasma renin activity was low." | 5.91 | [A Case of Aldosterone-Producing Adrenocortical Carcinoma]. ( Asai, S; Hashimoto, K; Ishihara, M; Kanamaru, S; Katsushima, H; Nakayasu, R; Oshiro, H; Shimizu, Y; Son, C; Tsuji, K; Utsunomiya, N, 2023) |
| "Aldosterone-producing adrenocortical carcinoma is a rare malignancy, which is usually diagnosed by histopathological examination of the excised tumor." | 5.43 | Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report. ( Ebisawa, T; Hayashi, T; Iuchi, H; Ohashi, K; Sakamoto, M; Sasano, H; Suzuki, H; Tojo, K; Utsunomiya, K, 2016) |
| "Moreover, aldosterone-producing adrenocortical carcinomas without hypertension are exceedingly rare, with only two previously reported cases." | 5.38 | Aldosterone-producing adrenocortical carcinoma without hypertension. ( Bae, SB; Kim, SJ; Kim, YJ; Seo, SW; Song, MS, 2012) |
| "We report a rare case of adrenocortical carcinoma." | 5.32 | Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. ( Azizlerli, H; Kapran, Y; Kurtulmus, N; Yarman, S, 2004) |
| " Here we demonstrate in human adrenocortical carcinoma (HAC15) cells that submaximal concentrations of angiotensin II and VLDL stimulate aldosterone production in an additive fashion, suggesting the possibility of common mechanisms of action." | 3.83 | VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production. ( Bollag, WB; Johnson, MH; Rainey, WE; Tsai, YY, 2016) |
| "Imaging with [¹²³I]iodometomidate ([¹²³I]IMTO) has been shown to diagnose adrenocortical lesions with high sensitivity and specificity." | 3.79 | [¹²³I]Iodometomidate imaging in adrenocortical carcinoma. ( Allolio, B; Bock, S; Buck, AK; Fassnacht, M; Haenscheid, H; Hahner, S; Knoedler, P; Kreissl, MC; Reiners, C; Saeger, W; Schirbel, A; Verburg, FA, 2013) |
| " The purpose of the present study was to determine the effect of endothelin-1 (ET-1) and angiotensin II (Ang II), two potent vasoconstrictors that are also involved in heart failure, on aldosterone secretion by human adrenocortical carcinoma NCIH295R cells grown in 96-well plates." | 3.72 | Synergistic stimulation of aldosterone production in human adrenocortical carcinoma NCI-H295R cells by endothelin-1 and angiotensin II. ( Hu, CW; Jeng, AY; Webb, RL, 2004) |
| "We present a case of oncocytic adrenocortical carcinoma in a 25-year-old man who presented with persistent hypertension, hypokalemia, and a large right adrenal mass." | 2.44 | Functional oncocytic adrenocortical carcinoma. ( Ali, AE; Raphael, SJ, 2007) |
| "Aldosterone-producing adrenocortical carcinoma (APAC) is a rare cause of hypertension often diagnosed late because of paucity of information." | 2.43 | Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. ( Fassina, A; Nussdorfer, GG; Pessina, AC; Rossi, GP; Seccia, TM, 2005) |
| "His aldosterone/renin ratio was high and plasma renin activity was low." | 1.91 | [A Case of Aldosterone-Producing Adrenocortical Carcinoma]. ( Asai, S; Hashimoto, K; Ishihara, M; Kanamaru, S; Katsushima, H; Nakayasu, R; Oshiro, H; Shimizu, Y; Son, C; Tsuji, K; Utsunomiya, N, 2023) |
| "Adrenocortical carcinoma is a heterogeneous and aggressive cancer that originates from steroidogenic cells within the adrenal cortex." | 1.72 | A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma. ( Abate, A; Berruti, A; Bornstein, SR; Bothou, C; Cosentini, D; Hantel, C; Peitzsch, M; Penton, D; Sigala, S; Tiberio, GAM, 2022) |
| "However, adrenocortical carcinomas (ACC) and primary aldosteronism (PA) are rare in MEN1." | 1.72 | Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma. ( Bourdeau, I; Corbeil, G; Duranceau, C; El-Haffaf, Z; Karakiewicz, PI; Lacroix, A; Latour, M; Parisien-La Salle, S, 2022) |
| "Subclinical hypercortisolism (SH) occurs in 5% to 30% of adrenal incidentalomas (AIs)." | 1.46 | Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas. ( Annamalai, AK; Dennedy, MC; Freeman, N; Graggaber, J; Gurnell, M; Halsall, DJ; Koulouri, O; Powlson, AS; Prankerd-Smith, O; Shaw, A; Vengopal, K, 2017) |
| "Aldosterone-producing adrenocortical carcinoma is a rare malignancy, which is usually diagnosed by histopathological examination of the excised tumor." | 1.43 | Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report. ( Ebisawa, T; Hayashi, T; Iuchi, H; Ohashi, K; Sakamoto, M; Sasano, H; Suzuki, H; Tojo, K; Utsunomiya, K, 2016) |
| "Primary aldosteronism (autonomous aldosterone production with suppressed renin) plays an important pathophysiological role in what has been previously labeled as essential hypertension." | 1.40 | Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism. ( Gordon, RD; Massimo, G; Murthy, M; O'Shaughnessy, KM; Stowasser, M; Wolley, M; Xu, S, 2014) |
| "Moreover, aldosterone-producing adrenocortical carcinomas without hypertension are exceedingly rare, with only two previously reported cases." | 1.38 | Aldosterone-producing adrenocortical carcinoma without hypertension. ( Bae, SB; Kim, SJ; Kim, YJ; Seo, SW; Song, MS, 2012) |
| "Exploratory laparotomy revealed adrenocortical carcinoma." | 1.33 | Unusual visualization of an adrenal carcinoma on NP-59 scintiscan. ( Chang, YH; Pan, CC; Tu, DG; Wang, FF; Won, JG, 2006) |
| "We report a rare case of adrenocortical carcinoma." | 1.32 | Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. ( Azizlerli, H; Kapran, Y; Kurtulmus, N; Yarman, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.08) | 18.7374 |
| 1990's | 1 (2.04) | 18.2507 |
| 2000's | 13 (26.53) | 29.6817 |
| 2010's | 24 (48.98) | 24.3611 |
| 2020's | 9 (18.37) | 2.80 |
| Authors | Studies |
|---|---|
| Shu, Q | 1 |
| Deng, M | 1 |
| Chen, Y | 1 |
| Liu, N | 1 |
| Cai, L | 1 |
| Sigala, S | 1 |
| Bothou, C | 1 |
| Penton, D | 1 |
| Abate, A | 1 |
| Peitzsch, M | 1 |
| Cosentini, D | 1 |
| Tiberio, GAM | 1 |
| Bornstein, SR | 1 |
| Berruti, A | 1 |
| Hantel, C | 1 |
| Porubayeva, EE | 1 |
| Pachuashvili, NV | 1 |
| Urusova, LS | 1 |
| Parisien-La Salle, S | 1 |
| Corbeil, G | 1 |
| El-Haffaf, Z | 1 |
| Duranceau, C | 1 |
| Latour, M | 1 |
| Karakiewicz, PI | 1 |
| Lacroix, A | 1 |
| Bourdeau, I | 1 |
| Ali, Y | 1 |
| Gomez-Sanchez, EP | 3 |
| Gomez-Sanchez, CE | 4 |
| Zhang, X | 1 |
| Lyu, Q | 1 |
| Ma, J | 1 |
| Pan, X | 1 |
| Wei, Q | 1 |
| Li, J | 2 |
| Zhu, Y | 1 |
| Shen, S | 1 |
| Ou, Y | 1 |
| Tong, N | 1 |
| Oshiro, H | 1 |
| Shimizu, Y | 1 |
| Nakayasu, R | 1 |
| Utsunomiya, N | 1 |
| Son, C | 1 |
| Tsuji, K | 1 |
| Asai, S | 1 |
| Katsushima, H | 1 |
| Ishihara, M | 1 |
| Hashimoto, K | 1 |
| Kanamaru, S | 1 |
| Ichijo, T | 1 |
| Ueshiba, H | 1 |
| Nawata, H | 1 |
| Yanase, T | 1 |
| Hussain, ZS | 1 |
| Rao, SS | 1 |
| Hussain, WZ | 1 |
| Puzhakkal, S | 1 |
| Kobuke, K | 2 |
| Oki, K | 3 |
| Ohno, H | 2 |
| Itcho, K | 2 |
| Yoshii, Y | 1 |
| Yoneda, M | 2 |
| Hattori, N | 2 |
| Kiseljak-Vassiliades, K | 1 |
| Zhang, Y | 2 |
| Bagby, SM | 1 |
| Kar, A | 1 |
| Pozdeyev, N | 1 |
| Xu, M | 1 |
| Gowan, K | 1 |
| Sharma, V | 1 |
| Raeburn, CD | 1 |
| Albuja-Cruz, M | 1 |
| Jones, KL | 1 |
| Fishbein, L | 1 |
| Schweppe, RE | 1 |
| Somerset, H | 1 |
| Pitts, TM | 1 |
| Leong, S | 1 |
| Wierman, ME | 1 |
| Attipa, C | 1 |
| Beck, S | 1 |
| Lipscomb, V | 1 |
| English, K | 1 |
| Carvalho, S | 1 |
| Kiupel, M | 1 |
| Szladovits, B | 1 |
| Peters, LM | 1 |
| Yang, Y | 1 |
| Xiao, M | 1 |
| Song, Y | 1 |
| Tang, Y | 1 |
| Luo, T | 1 |
| Yang, S | 1 |
| He, W | 1 |
| Cheng, Q | 1 |
| Ma, L | 1 |
| He, Y | 1 |
| Cao, Y | 1 |
| Yang, J | 1 |
| Peng, B | 1 |
| Hu, J | 1 |
| Li, Q | 1 |
| Kreissl, MC | 1 |
| Schirbel, A | 1 |
| Fassnacht, M | 1 |
| Haenscheid, H | 1 |
| Verburg, FA | 1 |
| Bock, S | 1 |
| Saeger, W | 1 |
| Knoedler, P | 1 |
| Reiners, C | 1 |
| Buck, AK | 1 |
| Allolio, B | 1 |
| Hahner, S | 1 |
| Murthy, M | 1 |
| Xu, S | 1 |
| Massimo, G | 1 |
| Wolley, M | 1 |
| Gordon, RD | 1 |
| Stowasser, M | 1 |
| O'Shaughnessy, KM | 2 |
| Griffin, AC | 1 |
| Kelz, R | 1 |
| LiVolsi, VA | 1 |
| Zhou, J | 1 |
| Shaikh, LH | 1 |
| Neogi, SG | 1 |
| McFarlane, I | 1 |
| Zhao, W | 1 |
| Figg, N | 1 |
| Brighton, CA | 1 |
| Maniero, C | 1 |
| Teo, AE | 1 |
| Azizan, EA | 1 |
| Brown, MJ | 1 |
| Ioachimescu, AG | 1 |
| Remer, EM | 1 |
| Hamrahian, AH | 1 |
| Nakamura, Y | 1 |
| Yamazaki, Y | 1 |
| Felizola, SJ | 1 |
| Ise, K | 1 |
| Morimoto, R | 1 |
| Satoh, F | 1 |
| Arai, Y | 1 |
| Sasano, H | 2 |
| Stindl, J | 1 |
| Tauber, P | 1 |
| Sterner, C | 1 |
| Tegtmeier, I | 1 |
| Warth, R | 2 |
| Bandulik, S | 1 |
| Ohashi, K | 1 |
| Hayashi, T | 1 |
| Sakamoto, M | 1 |
| Iuchi, H | 1 |
| Suzuki, H | 1 |
| Ebisawa, T | 1 |
| Tojo, K | 2 |
| Utsunomiya, K | 1 |
| Calissendorff, J | 1 |
| Calissendorff, F | 1 |
| Falhammar, H | 1 |
| Tsai, YY | 1 |
| Rainey, WE | 1 |
| Johnson, MH | 1 |
| Bollag, WB | 1 |
| Reimer, EN | 1 |
| Walenda, G | 1 |
| Seidel, E | 1 |
| Scholl, UI | 1 |
| Uchida, T | 1 |
| Nishimoto, K | 1 |
| Fukumura, Y | 1 |
| Asahina, M | 1 |
| Goto, H | 1 |
| Kawano, Y | 1 |
| Shimizu, F | 1 |
| Tsujimura, A | 1 |
| Seki, T | 1 |
| Mukai, K | 1 |
| Kabe, Y | 1 |
| Suematsu, M | 1 |
| Yao, T | 1 |
| Horie, S | 1 |
| Watada, H | 1 |
| Dennedy, MC | 1 |
| Annamalai, AK | 1 |
| Prankerd-Smith, O | 1 |
| Freeman, N | 1 |
| Vengopal, K | 1 |
| Graggaber, J | 1 |
| Koulouri, O | 1 |
| Powlson, AS | 1 |
| Shaw, A | 1 |
| Halsall, DJ | 1 |
| Gurnell, M | 1 |
| Brenner, T | 1 |
| Isaka, T | 1 |
| Ikeda, K | 1 |
| Takada, Y | 1 |
| Inada, Y | 1 |
| Tajima, N | 1 |
| Johnsen, IK | 1 |
| Kappler, R | 1 |
| Auernhammer, CJ | 1 |
| Beuschlein, F | 2 |
| Lawnicka, H | 1 |
| Kowalewicz-Kulbat, M | 1 |
| Sicinska, P | 1 |
| Kazimierczuk, Z | 1 |
| Grieb, P | 1 |
| Stepien, H | 1 |
| Plonczynski, MW | 1 |
| Luis Lam, M | 1 |
| Williams, TA | 1 |
| Monticone, S | 1 |
| Crudo, V | 1 |
| Veglio, F | 1 |
| Mulatero, P | 1 |
| Zennaro, MC | 1 |
| Song, MS | 1 |
| Seo, SW | 1 |
| Bae, SB | 1 |
| Kim, YJ | 1 |
| Kim, SJ | 1 |
| Lichtenauer, UD | 1 |
| Shapiro, I | 1 |
| Osswald, A | 1 |
| Meurer, S | 1 |
| Kulle, A | 1 |
| Reincke, M | 1 |
| Riepe, F | 1 |
| JACKSON, WP | 1 |
| ZILBERG, B | 1 |
| LEWIS, B | 1 |
| McKENZIE, D | 1 |
| EYMONTT, MJ | 1 |
| GWINUP, G | 1 |
| KRUGER, FA | 1 |
| MAYNARD, DE | 1 |
| HAMWI, GJ | 1 |
| Kurtulmus, N | 1 |
| Yarman, S | 1 |
| Azizlerli, H | 1 |
| Kapran, Y | 1 |
| Shen, WT | 1 |
| Sturgeon, C | 1 |
| Duh, QY | 1 |
| Seccia, TM | 1 |
| Fassina, A | 1 |
| Nussdorfer, GG | 1 |
| Pessina, AC | 1 |
| Rossi, GP | 1 |
| Hu, CW | 1 |
| Webb, RL | 1 |
| Jeng, AY | 1 |
| Sun, X | 1 |
| Ayala, A | 1 |
| Castro, CY | 1 |
| Aiba, M | 1 |
| Fujibayashi, M | 1 |
| Wang, FF | 1 |
| Chang, YH | 1 |
| Pan, CC | 1 |
| Tu, DG | 1 |
| Won, JG | 1 |
| Carmona-Bayonas, A | 1 |
| Soler, IO | 1 |
| Gómez, FI | 1 |
| Billalabeitia, EG | 1 |
| Saura, HP | 1 |
| Tafalla, MS | 1 |
| Díaz, MP | 1 |
| Ali, AE | 1 |
| Raphael, SJ | 1 |
| Machida, T | 1 |
| Uchida, E | 1 |
| Matsuda, K | 1 |
| Hirayama, K | 1 |
| Yoshii, K | 1 |
| Takiguchi, M | 1 |
| Taniyama, H | 1 |
| Peñuela Melero, S | 1 |
| Sancho Bueso, T | 1 |
| Martínez Muñoz, I | 1 |
| Riestra Martínez, ML | 1 |
| García Puig, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Prevalence and Characteristics of Adrenal Incidentaloma: A Prospective Study[NCT04682938] | 25,356 participants (Actual) | Observational | 2020-11-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for aldosterone and Adrenocortical Carcinoma
| Article | Year |
|---|---|
Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aged; Aldosterone; Female; Humans; Hyperaldoster | 2014 |
Adrenal incidentalomas: a disease of modern technology offering opportunities for improved patient care.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; | 2015 |
Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Androgens; Estrogens; Humans; Hydro | 2015 |
From incidentaloma to adrenocortical carcinoma: the surgical management of adrenal tumors.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adrenoco | 2005 |
Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course.
Topics: Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Female; Humans; Middle Aged; | 2005 |
Functional oncocytic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Humans; Hydrocortisone; Male | 2007 |
43 other studies available for aldosterone and Adrenocortical Carcinoma
| Article | Year |
|---|---|
Imaging Aldosterone-Producing Adrenocortical Carcinoma With 68 Ga-Pentixafor PET/CT.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Coordination Complexes; Humans; Pep | 2022 |
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldoste | 2022 |
[Multifactorial assessment of prognostic features of adrenocortical cancer].
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Aldo | 2022 |
Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical C | 2022 |
Mammalian Target of Rapamycin Inhibition Decreases Angiotensin II-Induced Steroidogenesis in HAC15 Human Adrenocortical Carcinoma Cells.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Humans; Hydrocortis | 2022 |
Clinical characteristics and pre-surgery diagnostic criteria of aldosterone-producing adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Humans | 2022 |
[A Case of Aldosterone-Producing Adrenocortical Carcinoma].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Humans; Male; Middle Aged; Mitotane | 2023 |
A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortica | 2020 |
Potassium losing, aldosterone producing adrenocortical carcinoma: a rare presentation.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aldosteron | 2020 |
Calneuron 1 Increased Ca
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Adult; Aldosterone; Anim | 2018 |
Development of new preclinical models to advance adrenocortical carcinoma research.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Cell Line, Tumor; C | 2018 |
Angiotensin 1-7 suppresses angiotensin II mediated aldosterone production via JAK/STAT signaling inhibition.
Topics: Adrenocortical Carcinoma; Aldosterone; Angiotensin I; Angiotensin II; Cardiovascular Diseases; Cell | 2019 |
Aldosterone-producing adrenocortical carcinoma with myxoid differentiation in a cat.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Animals; Biopsy; Ca | 2018 |
H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aldosterone; Cell Nucleus; | 2019 |
[¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aldosterone; Cohort | 2013 |
Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Amino Acid Sequence; Animals | 2014 |
DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion.
Topics: Adrenocortical Carcinoma; Aldosterone; Disease Progression; Eye Proteins; Female; Gene Expression Re | 2015 |
Pathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na(+)/K(+)-ATPase.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Aldoster | 2015 |
Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aged; Aldosterone; Biopsy; Female; Humans; Liver | 2016 |
Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids - experience from a single centre spanning three decades.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcino | 2016 |
VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.
Topics: Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Cell Line, Tumor; Cells, Cultured; Extracellu | 2016 |
CACNA1H(M1549V) Mutant Calcium Channel Causes Autonomous Aldosterone Production in HAC15 Cells and Is Inhibited by Mibefradil.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Amino Acid Substitution; Calcium Ch | 2016 |
Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Cushing Syndrome; Cytochrome | 2017 |
Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Ad | 2017 |
Both TASK-3 and TREK-1 two-pore loop K channels are expressed in H295R cells and modulate their membrane potential and aldosterone secretion.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Cell Line, Tumor; Fluorescence; Gen | 2008 |
Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Azetidinecarboxylic | 2009 |
Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Blotting, Western; Bone Morphogenet | 2009 |
Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocortical Carc | 2010 |
Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Calcium; Calcium Channel Blockers; | 2012 |
Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Apoptosis; Calcium; Cell Line, Tumo | 2012 |
Primary aldosteronism takes (KCNJ)five!
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; G Protein-Coupled Inwardly-Rectifyi | 2012 |
Aldosterone-producing adrenocortical carcinoma without hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aldosterone; Biopsy; Femal | 2012 |
Characterization of NCI-H295R cells as an in vitro model of hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Cell Adhesion; Cell Line, Tumor; Cy | 2013 |
Cushing's syndrome in childhood; report of case of adrenocortical carcinoma with excessive aldosterone production.
Topics: Adrenocortical Carcinoma; Aldosterone; Child; Cushing Syndrome; Humans; Infant | 1958 |
CUSHING'S SYNDROME WITH HYPOGLYCEMIA CAUSED BY ADRENOCORTICAL CARCINOMA.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Aldos | 1965 |
Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Diuretics; Female; Histocyto | 2004 |
Synergistic stimulation of aldosterone production in human adrenocortical carcinoma NCI-H295R cells by endothelin-1 and angiotensin II.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Cell Line, Tumor; D | 2004 |
Adrenocortical carcinoma with concomitant myelolipoma in a patient with hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aldosterone; Biomarkers, T | 2005 |
Histopathological diagnosis and prognostic factors in adrenocortical carcinoma.
Topics: Adenoma, Oxyphilic; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and ov | 2005 |
Unusual visualization of an adrenal carcinoma on NP-59 scintiscan.
Topics: Adolescent; Adosterol; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Dehydroepian | 2006 |
Tailored hormonal therapy in secretory adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Ang | 2007 |
Aldosterone-, corticosterone- and cortisol-secreting adrenocortical carcinoma in a dog: case report.
Topics: Adrenal Glands; Adrenocortical Carcinoma; Aldosterone; Animals; Corticosterone; Dihydrotestosterone; | 2008 |
[Woman with refractory hypertension and hypokalemia].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adrenocorticotrop | 1999 |